Vaccines

RSV Vaccine

This study will evaluate the safety and effectiveness of an RSV vaccine in women between the ages of 18-45 to increase antibodies to RSV infection. The study will last approximately 6 months with 4 visits to our office and 1 telephone call. Compensation is available for time and travel up to $600, for those who qualify.

*Compensation for time and travel may be available to those who qualify.

Smallpox Vaccine

This research study will evaluate the safety and effectiveness of a vaccine to protect against Smallpox. This study will last approximately up to 39 weeks with 6 number of visits to our office and 1 telephone call. While the World Health Organization officially declared successful global eradication in 1980, the threat of a small pox outbreak still exists through bioterrorism and risk of natural re-emergence of the virus.

*Compensation for time and travel may be available to those who qualify.

E. Coli Vaccine

RCR is currently enrolling healthy 60-85 year olds to evaluate a vaccine that could potentially prevent E. Coli that can cause sepsis.

*Compensation for time and travel may be available to those who qualify.

Lyme Disease Vaccine (12 Months)

Prevention of Lyme disease will help reduce the lifetime complications the disease may bring if the disease is not caught early enough. The purpose of this study is to evaluate the effectiveness of an investigational Lyme disease vaccine. This study will be conducted over a 12 month period with 8 in-person visits to our office.

*Compensation for time and travel may be available to those who qualify.

Pediatrics Meningitis Vaccine

Two month old patients of Legacy Pediatrics may have an opportunity to participate in this study.

C. Diff. Vaccine

Investigational vaccine to prevent Clostridium Difficile

*Compensation for time and travel may be available to those who qualify.